LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

LAVA Therapeutics NV
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LAVA Therapeutics NV
Accounts Payable Peer Comparison

Comparables:
PHARM
PRQR
QURE
ARGX
MRUS

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Accounts Payable
$4.4m
CAGR 3-Years
70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Accounts Payable
$72.5m
CAGR 3-Years
25%
CAGR 5-Years
20%
CAGR 10-Years
36%
ProQR Therapeutics NV
NASDAQ:PRQR
Accounts Payable
€33k
CAGR 3-Years
-52%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Accounts Payable
$5.4m
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
1%
argenx SE
XBRU:ARGX
Accounts Payable
$280.6m
CAGR 3-Years
5%
CAGR 5-Years
38%
CAGR 10-Years
62%
Merus NV
NASDAQ:MRUS
Accounts Payable
$6.2m
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
N/A

See Also

What is LAVA Therapeutics NV's Accounts Payable?
Accounts Payable
4.4m USD

Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Accounts Payable amounts to 4.4m USD.

What is LAVA Therapeutics NV's Accounts Payable growth rate?
Accounts Payable CAGR 3Y
70%

Over the last year, the Accounts Payable growth was 11%. The average annual Accounts Payable growth rates for LAVA Therapeutics NV have been 70% over the past three years .

Back to Top